A 16 Week Study to Evaluate the Efficacy and Safety of PF-06882961 in Adults With Type 2 Diabetes Mellitus
Public ClinicalTrials.gov record NCT03985293. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A 16-WEEK, PHASE 2B, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL GROUP STUDY TO EVALUATE THE EFFICACY AND SAFETY OF TWICE DAILY PF-06882961 ADMINISTRATION IN ADULTS WITH TYPE 2 DIABETES MELLITUS INADEQUATELY CONTROLLED ON METFORMIN OR DIET AND EXERCISE
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This multicenter, randomized, double-blind, placebo controlled, parallel group study is being conducted to provide data on efficacy, safety, tolerability and pharmacokinetics (PK) of multiple dose levels of PF-06882961 in adults with type 2 diabetes mellitus (T2DM) inadequately controlled on metformin and/or diet and exercise. In addition, the study is intended to enable selection of efficacious doses for future clinical development of PF-06882961.
Study identification
- NCT ID
- NCT03985293
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 412 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 15, 2019 (Actual)
- Primary completion
- Jun 8, 2021 (Actual)
- Completion
- Jul 7, 2021 (Actual)
- Last update posted
- Jun 30, 2022
2019 – 2021
United States locations
- U.S. sites
- 42
- U.S. states
- 15
- U.S. cities
- 36
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Holy Trinity Medical Clinic | Harbor City | California | 90710 | — |
| Innovative Clinical Research, Inc. | Harbor City | California | 90710 | — |
| Long Beach Clinical Trials Services, Inc. | Long Beach | California | 90806 | — |
| National Research Institute | Los Angeles | California | 90057 | — |
| Catalina Research Institute, LLC | Montclair | California | 91763 | — |
| Empire Clinical Research | Pomona | California | 91767 | — |
| Rancho Cucamonga Clinical Research | Rancho Cucamonga | California | 91730 | — |
| Encompass Clinical Research | Spring Valley | California | 91978 | — |
| University Clinical Investigators, Incorporated | Tustin | California | 92780 | — |
| San Fernando Valley Health Institute, LLC | Van Nuys | California | 91405 | — |
| Diablo Clinical Research Incorporated | Walnut Creek | California | 94598 | — |
| Accel Research Sites - DeLand Clinical Research Unit | DeLand | Florida | 32720 | — |
| East Coast Institute for Research, LLC | Jacksonville | Florida | 32204 | — |
| East Coast Institute for Research, LLC | Jacksonville | Florida | 32216 | — |
| New Horizon Research Center | Miami | Florida | 33165 | — |
| NewPhase Clinical Trials, Corp. | Miami Beach | Florida | 33140 | — |
| Sunshine Research Center, Inc | Opa-locka | Florida | 33054 | — |
| Andres Patron D.O. P.A. | Pembroke Pines | Florida | 33026 | — |
| Ellipsis Group | Alpharetta | Georgia | 30022 | — |
| East Coast Institute for Research, LLC | Macon | Georgia | 31210 | — |
| Cedar Crosse Research Center | Chicago | Illinois | 60607 | — |
| Buynak Clinical Research | Valparaiso | Indiana | 46383 | — |
| Viable Research Management LLC | Henderson | Nevada | 89014 | — |
| Premier Research | Trenton | New Jersey | 08611 | — |
| PharmQuest | Greensboro | North Carolina | 27408 | — |
| Lillestol Research LLC | Fargo | North Dakota | 58104 | — |
| Velocity Clinical Research | Cincinnati | Ohio | 45242 | — |
| Conrad Clinical Research | Edmond | Oklahoma | 73013 | — |
| Family Medical Associates | Levittown | Pennsylvania | 19056 | — |
| Preferred Primary Care Physicians, Inc. | Pittsburgh | Pennsylvania | 15236 | — |
| Spartanburg Medical Research | Spartanburg | South Carolina | 29303 | — |
| Palmetto Clinical Research | Summerville | South Carolina | 29485 | — |
| Palmetto Primary Care Physicians (physicals only) | Summerville | South Carolina | 29485 | — |
| Dallas Diabetes Research Center | Dallas | Texas | 75230 | — |
| Endocrine Associates | Houston | Texas | 77004 | — |
| PrimeCare Medical Group | Houston | Texas | 77024 | — |
| Juno Research, LLC | Houston | Texas | 77074 | — |
| Northeast Clinical Research of San Antonio | Live Oak | Texas | 78233 | — |
| Sun Research Institute | San Antonio | Texas | 78215 | — |
| DM Clinical Research | Tomball | Texas | 77375 | — |
| Martin Diagnostic Clinic | Tomball | Texas | 77375 | — |
| Rainier Clinical Research Center, Inc. | Renton | Washington | 98057 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 41 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03985293, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 30, 2022 · Synced Oct 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03985293 live on ClinicalTrials.gov.